Targeted radiation therapy for advanced osteosarcoma
Part of Cancer clinical trials.
This trial tests a new targeted radiation treatment (177Lu-TARGETed Osteosarcoma Therapy) for people with advanced osteosarcoma that has not responded to or has come back after prior chemotherapy. The goal is to see if this treatment can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have osteosarcoma (a type of bone cancer) that has come back or not responded to standard treatment.
- You have been through at least one round of chemotherapy.
- You are at least 12 years old (or 18 for the first group).
- You weigh at least 30 kilograms (about 66 pounds).
- You are not pregnant or breastfeeding.
- You are willing to have a fresh or stored tumor sample available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether adding losartan to sunitinib can help control osteosarcoma that has returned or keeps growing after at least one prior treatment. It may help by targeting the cancer’s growth signals and blood supply, but the goal at this stage is mainly to check safety and find workable dosing.
This trial is testing a new type of radiation therapy for advanced soft tissue sarcoma that has not responded to other treatments. The goal is to see if this therapy can shrink tumors and help control the cancer.
This trial tests whether combining an immunotherapy drug (atezolizumab) with focused radiation and surgery can help people whose osteosarcoma has come back only in the lungs. It aims to see if this approach is safe and may improve outcomes.
This Phase 2 trial tests a highly focused radiation treatment to shrink sarcoma that has spread to a limited number of spots in the body. It may help control disease while limiting radiation to healthier tissue.
This trial tests a single, high-dose internal radiation treatment (brachytherapy) for large osteosarcoma tumors that can't be removed by surgery and haven't responded to other treatments. It may offer a new option for shrinking these difficult-to-treat masses.
This trial tests a combination of immunotherapy and targeted radiation before surgery for osteosarcoma that has spread to the lungs. It aims to see if this approach can help shrink or control the lung tumors and make surgery more effective.
Hear when a new Relapsed / Refractory Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.